Gene-Edited Pig Kidney Transplant Shows Promise in Human Patient
Towana Looney, a patient with kidney failure, received a genetically modified pig kidney transplant at NYU Langone Health and is recovering well, exceeding previous survival rates of similar procedures and raising hope for a potential solution to the organ shortage.
Gene-Edited Pig Kidney Transplant Shows Promise in Human Patient
Towana Looney, a patient with kidney failure, received a genetically modified pig kidney transplant at NYU Langone Health and is recovering well, exceeding previous survival rates of similar procedures and raising hope for a potential solution to the organ shortage.
Progress
40% Bias Score
Xenotransplantation Clinical Trials Planned for 2025
Two U.S. companies plan to begin the world's first clinical trials of xenotransplantation in 2025 using pig organs, driven by a critical shortage of human donor organs and the recent success of a pig kidney transplant in an Alabama woman who had been on dialysis for eight years, though previous atte...
Xenotransplantation Clinical Trials Planned for 2025
Two U.S. companies plan to begin the world's first clinical trials of xenotransplantation in 2025 using pig organs, driven by a critical shortage of human donor organs and the recent success of a pig kidney transplant in an Alabama woman who had been on dialysis for eight years, though previous atte...
Progress
40% Bias Score
Russian Doctors Revive Patient's Heart 3.5 Hours After Cardiac Arrest
Doctors in Krasnoyarsk, Russia, revived a patient's heart 3.5 hours after cardiac arrest using ECMO and invasive warming; the patient, found hypothermic (19.8°C) at a bus stop, regained consciousness within 24 hours and is recovering.
Russian Doctors Revive Patient's Heart 3.5 Hours After Cardiac Arrest
Doctors in Krasnoyarsk, Russia, revived a patient's heart 3.5 hours after cardiac arrest using ECMO and invasive warming; the patient, found hypothermic (19.8°C) at a bus stop, regained consciousness within 24 hours and is recovering.
Progress
40% Bias Score
Deep Brain Stimulation Enables Paralyzed Patients to Walk
Two paralyzed patients regained significant mobility, including walking and stair climbing, after deep brain stimulation (DBS) therapy targeting the lateral hypothalamus, a brain region not previously linked to leg control in humans; the study, published in Nature Medicine, suggests a potential brea...
Deep Brain Stimulation Enables Paralyzed Patients to Walk
Two paralyzed patients regained significant mobility, including walking and stair climbing, after deep brain stimulation (DBS) therapy targeting the lateral hypothalamus, a brain region not previously linked to leg control in humans; the study, published in Nature Medicine, suggests a potential brea...
Progress
52% Bias Score
Successful Pig Kidney Transplant Shows Promise for Organ Failure
A 53-year-old Alabama woman, Towana Looney, is thriving after receiving a genetically modified pig kidney transplant at NYU Langone Health in November 2024; this is a significant advancement in xenotransplantation following previous setbacks.
Successful Pig Kidney Transplant Shows Promise for Organ Failure
A 53-year-old Alabama woman, Towana Looney, is thriving after receiving a genetically modified pig kidney transplant at NYU Langone Health in November 2024; this is a significant advancement in xenotransplantation following previous setbacks.
Progress
52% Bias Score
Successful Pig Kidney Transplant Offers Hope for Thousands Awaiting Organs
An Alabama woman is thriving after receiving a pig kidney transplant, becoming the third living person to undergo this procedure; this development holds significant promise for the 90,000 Americans awaiting kidney transplants, given the high demand for kidneys and limited donor organs.
Successful Pig Kidney Transplant Offers Hope for Thousands Awaiting Organs
An Alabama woman is thriving after receiving a pig kidney transplant, becoming the third living person to undergo this procedure; this development holds significant promise for the 90,000 Americans awaiting kidney transplants, given the high demand for kidneys and limited donor organs.
Progress
40% Bias Score
Lenacapavir: Six-Monthly HIV Prevention Injection Named "Science" Breakthrough of the Year
"Science" magazine selected Lenacapavir, a six-monthly HIV-prevention injection, as its 2024 Breakthrough of the Year due to its superior efficacy and convenience compared to daily pills, potentially impacting global HIV prevention efforts.
Lenacapavir: Six-Monthly HIV Prevention Injection Named "Science" Breakthrough of the Year
"Science" magazine selected Lenacapavir, a six-monthly HIV-prevention injection, as its 2024 Breakthrough of the Year due to its superior efficacy and convenience compared to daily pills, potentially impacting global HIV prevention efforts.
Progress
36% Bias Score
EMA Approves Leqembi for Alzheimer's
The European Medicines Agency approves Leqembi, a new Alzheimer's treatment to reduce cognitive decline in early-stage patients. The drug targets amyloid plaques in the brain and has already received approvals in other countries.
EMA Approves Leqembi for Alzheimer's
The European Medicines Agency approves Leqembi, a new Alzheimer's treatment to reduce cognitive decline in early-stage patients. The drug targets amyloid plaques in the brain and has already received approvals in other countries.
Progress
0% Bias Score